206 related articles for article (PubMed ID: 30457473)
41. Cytochrome P450 reaction phenotyping and inhibition and induction studies of pinostrobin in human liver microsomes and hepatocytes.
Tan S; Dong Z; Zhang J; Efferth T; Fu Y; Hua X
Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 28111763
[TBL] [Abstract][Full Text] [Related]
42. Metabolic drug-drug interaction potential of macrolactin A and 7-O-succinyl macrolactin A assessed by evaluating cytochrome P450 inhibition and induction and UDP-glucuronosyltransferase inhibition in vitro.
Bae SH; Kwon MJ; Park JB; Kim D; Kim DH; Kang JS; Kim CG; Oh E; Bae SK
Antimicrob Agents Chemother; 2014 Sep; 58(9):5036-46. PubMed ID: 24890600
[TBL] [Abstract][Full Text] [Related]
43. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
44. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.
Gong EC; Chea S; Balupuri A; Kang NS; Chin YW; Choi YH
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498658
[TBL] [Abstract][Full Text] [Related]
45. Potent inhibitory effect of alpha-viniferin on human cytochrome P450.
Sim J; Jang HW; Song M; Kim JH; Lee SH; Lee S
Food Chem Toxicol; 2014 Jul; 69():276-80. PubMed ID: 24769006
[TBL] [Abstract][Full Text] [Related]
46. Identification and characterization of potent CYP2D6 inhibitors in lotus leaves.
Ye LH; He XX; Kong LT; Liao YH; Pan RL; Xiao BX; Liu XM; Chang Q
J Ethnopharmacol; 2014 Apr; 153(1):190-6. PubMed ID: 24561383
[TBL] [Abstract][Full Text] [Related]
47. In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes.
Ventura V; Solà J; Peraire C; Brée F; Obach R
Drug Metab Dispos; 2012 Jul; 40(7):1268-78. PubMed ID: 22451700
[TBL] [Abstract][Full Text] [Related]
48. The potential of Epimedium koreanum Nakai for herb-drug interaction.
Zhong Q; Shi Z; Zhang L; Zhong R; Xia Z; Wang J; Wu H; Jiang Y; Sun E; Wei Y; Feng L; Zhang Z; Liu D; Song J; Jia X
J Pharm Pharmacol; 2017 Oct; 69(10):1398-1408. PubMed ID: 28653752
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of UGT2B7 Enzyme Activity in Human and Rat Liver Microsomes by Herbal Constituents.
Abdullah NH; Ismail S
Molecules; 2018 Oct; 23(10):. PubMed ID: 30347696
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of DA-9801, a new herbal drug for diabetic neuropathy, on metabolism-mediated interaction.
Ji HY; Liu KH; Kong TY; Jeong HU; Choi SZ; Son M; Cho YY; Lee HS
Arch Pharm Res; 2013 Jan; 36(1):1-5. PubMed ID: 23371804
[TBL] [Abstract][Full Text] [Related]
52. An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides.
Kazmi F; Yerino P; McCoy C; Parkinson A; Buckley DB; Ogilvie BW
Drug Metab Dispos; 2018 Aug; 46(8):1066-1074. PubMed ID: 29735754
[TBL] [Abstract][Full Text] [Related]
53. Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro.
Cheng HX; Lu YY; Wang X; Ren H; Li Q; Wang SM; Ding Y; Lou YQ; Zhang GL
Eur J Pharm Sci; 2018 Oct; 123():241-248. PubMed ID: 30010032
[TBL] [Abstract][Full Text] [Related]
54. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
[TBL] [Abstract][Full Text] [Related]
55. In vitro inhibition of human liver drug metabolizing enzymes by second generation antihistamines.
Nicolas JM; Whomsley R; Collart P; Roba J
Chem Biol Interact; 1999 Nov; 123(1):63-79. PubMed ID: 10597902
[TBL] [Abstract][Full Text] [Related]
56. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study.
Obach RS; Cox LM; Tremaine LM
Drug Metab Dispos; 2005 Feb; 33(2):262-70. PubMed ID: 15547048
[TBL] [Abstract][Full Text] [Related]
57. Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs-Implication for Herb-Drug Interaction.
Fasinu PS; Manda VK; Dale OR; Egiebor NO; Walker LA; Khan SI
Molecules; 2017 Nov; 22(12):. PubMed ID: 29168799
[TBL] [Abstract][Full Text] [Related]
58. Anti-inflammatory activity of Eupatorium perfoliatum L. extracts, eupafolin, and dimeric guaianolide via iNOS inhibitory activity and modulation of inflammation-related cytokines and chemokines.
Maas M; Deters AM; Hensel A
J Ethnopharmacol; 2011 Sep; 137(1):371-81. PubMed ID: 21669270
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay.
Pandit S; Kanjilal S; Awasthi A; Chaudhary A; Banerjee D; Bhatt BN; Narwaria A; Singh R; Dutta K; Jaggi M; Singh AT; Sharma N; Katiyar CK
J Ethnopharmacol; 2017 Feb; 197():165-172. PubMed ID: 27457692
[TBL] [Abstract][Full Text] [Related]
60. In vitro assessment of cytochrome P450 inhibition and induction potential of felotaxel (SHR110008).
Ding Y; Jia Y; Lu C; Liu W; Yang J; Song Y; Zhu Y; Yang L; Ding L; Wen A
Biomed Pharmacother; 2012 Jun; 66(4):318-21. PubMed ID: 22397757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
